Nivolumab (NIVO) + Chemotherapy (chemo) Vs Chemo As First-Line (1L) Treatment for Advanced Gastric Cancer/gastroesophageal Junction Cancer/esophageal Adenocarcinoma (GC/GEJC/EAC): 5-Year (y) Follow-Up Results from CheckMate 649.
Journal of Clinical Oncology(2025)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要